A new trading day began on Monday, with Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) stock price down -3.63% from the previous day of trading, before settling in for the closing price of $12.39. TNXP’s price has ranged from $10.82 to $1248.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 95.88%. With a float of $5.59 million, this company’s outstanding shares have now reached $155.63 million.
Let’s determine the extent of company efficiency that accounts for 103 employees. In terms of profitability, gross margin is 7.54%, operating margin of -731.49%, and the pretax margin is -1197.86%.
Tonix Pharmaceuticals Holding Corp (TNXP) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.00%, while institutional ownership is 1.85%.
Tonix Pharmaceuticals Holding Corp (TNXP) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -640 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 95.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 78.59% during the next five years compared to 79.31% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Here are Tonix Pharmaceuticals Holding Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -20.56, a number that is poised to hit -18.50 in the next quarter and is forecasted to reach -62.00 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Looking closely at Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP), its last 5-days average volume was 3.54 million, which is a jump from its year-to-date volume of 1.62 million. As of the previous 9 days, the stock’s Stochastic %D was 2.24%. Additionally, its Average True Range was 8.02.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 0.94%, which indicates a significant decrease from 2.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 402.85% in the past 14 days, which was higher than the 249.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.58, while its 200-day Moving Average is $119.61. However, in the short run, Tonix Pharmaceuticals Holding Corp’s stock first resistance to watch stands at $12.56. Second resistance stands at $13.18. The third major resistance level sits at $13.61. If the price goes on to break the first support level at $11.51, it is likely to go to the next support level at $11.08. Now, if the price goes above the second support level, the third support stands at $10.46.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
With a market capitalization of 66.75 million, the company has a total of 1,869K Shares Outstanding. Currently, annual sales are 7,770 K while annual income is -116,660 K. The company’s previous quarter sales were 2,820 K while its latest quarter income was -14,210 K.
